This inventor holds 1 USPTO granted patent. Top assignee: Santen Sas. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: **Innovative Approaches in Eye Treatment: The Contributions of Laura Rabinovich**
Introduction
Laura Rabinovich is an inspiring inventor based in Kadima, IL, who has made noteworthy contributions to the field of ophthalmology. With a keen focus on improving therapeutic techniques, she has developed a novel invention that addresses the challenges faced in treating eye diseases and conditions.
Latest Patents
Rabinovich holds a patent for her innovative approach titled "Topical methods and compositions for the treatment of eye diseases and conditions." This patent presents a groundbreaking therapeutic method that facilitates the delivery of corticosteroids to the eye's surface without inducing the typical side effects linked to conventional topical applications. Specifically, her invention utilizes corticosteroid prodrugs, such as dexamethasone palmitate, to enhance treatment efficacy and safety. The patent also includes pharmaceutical compositions and kits designed to implement these treatment methods effectively.
Career Highlights
Laura Rabinovich is affiliated with Santen Sas, a well-regarded company specializing in ophthalmic treatments. Her work in this organization has allowed her to focus on innovative solutions that significantly benefit patients suffering from various eye conditions.
Collaborations
Throughout her career, Rabinovich has collaborated with notable professionals in her field, including Gregory Lambert and Frederic Lallemand. These partnerships have enabled her to refine her inventions and contribute to the advancement of eye care.
Conclusion
Laura Rabinovich's dedication to developing innovative treatments for eye diseases positions her as a key figure in the realm of ophthalmology. Her patent demonstrates her commitment to enhancing patient care and improving therapeutic outcomes, thereby making a significant impact on the industry. As she continues her work at Santen Sas, her contributions will likely pave the way for further advancements in eye health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile